Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tininurad Tablets in Hyperuricemia With or Without Gout
CTR20223008Phase 2Completed
- Sponsor
- Tianjin Institute of Pharmaceutical Research
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tininurad in hyperuricemia, gout, sponsored by Tianjin Institute of Pharmaceutical Research. Started Nov 2022; status: completed.
02
Drugs
tininurad
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on CTR20223008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20223008.